Abstract
Purpose
To evaluate the combined effect of marker states and a prompt on the reliability and validity of direct utility assessment.
Methods
In a structured interview, 141 prostate cancer (PC) patients provided rating scale (RS) and standard gamble (SG) utilities for their “own health” (RS−/SG−). Following self-completion of comparison instruments (two generic utility and one disease-specific psychometric), they answered a checklist of PC-related items (a prompt to consider self-health) and provided utilities for self-health and mild and severe PC marker states (RS+/SG+). The interview was repeated 5 weeks later, but without comparison instruments. Using Bayesian modeling, we computed and compared correlation coefficients to assess RS and SG test–retest reliability and validity and the effects of the prompt and marker states.
Results
RS and SG had acceptable test–retest reliability (intraclass correlation coefficients = 0.57–0.63). The prompt and marker states decreased the reliability of the RS by 0.01 (from 0.58 to 0.57) but increased the reliability of the SG by 0.05 (from 0.58 to 0.63). The probability that the reliability of the SG+ was greater than that of the SG− was very high (0.96). Correlations with comparison instruments were higher by 0.01–0.06 for RS+ vs RS−, and higher by 0.03–0.06 for SG+ vs SG−. The probabilities that the prompt and marker states improved validity ranged from 0.55 to 0.74 (RS), and from 0.61 to 0.70 (SG).
Conclusions
A self-health description prompt and marker states modestly improved the reliability and validity of direct utility elicitation.
Similar content being viewed by others
Abbreviations
- RS:
-
Rating scale
- SG:
-
Standard gamble
- RS−:
-
Rating scale administered without prompt and marker states
- RS+:
-
Rating scale administered with prompt and marker states
- SG−:
-
Standard gamble administered without prompt and marker states
- SG+:
-
Standard gamble administered with prompt and marker states
- HUI:
-
Health Utilities Index
- HUI3:
-
Health Utilities Index, Mark 3
- QWB:
-
Quality of Well-Being Scale
- PORPUS-U:
-
Patient-oriented prostate utility scale—utility
- PORPUS-P:
-
Patient-oriented prostate utility scale—profile
- FACT-P:
-
Functional Assessment of Cancer Therapy—Prostate
- T1:
-
First interview (time 1)
- T2:
-
Second interview (time 2)
- ICC:
-
Intraclass correlation coefficient
- SD:
-
Standard deviation
- CrI:
-
Credible interval
References
Gold, M. R, Patrick, D. L, Torrance, G. W., Fryback, D. G., Hadorn, D. C., Kamlet, M. S. et al. (1996). Identifying and valuing outcomes. In M. R. Gold, J. E. Siegel, L. B. Russell & M. C. Weinstein (Eds.), Cost effectiveness in health and medicine (pp. 82–134). New York: Oxford University Press.
Neumann, P. J., Goldie, S. J., & Weinstein, M. C. (2000). Preference-based measures in economic evaluation in health care. Annual Review of Public Health, 21, 587–611.
Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences-II: Scaling methods. Journal of Clinical Epidemiology, 42, 459–471.
Feeny, D. H., Torrance, G. W., & Furlong, W. J. (1996). Health utilities index. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (2nd ed, pp. 239–252). Philadelphia: Lippincourt-Raven Publishers.
von Neumann, J., & Morgenstern, O. (1944). Theory of games and economic behavior. Princeton, N.J.: Princeton University Press.
Torrance, G. W., Furlong, W., Feeny, D., & Boyle, M. (1995). Multi-attribute preference functions: Health utilities index. PharmacoEconomics, 7, 503–520.
Kaplan, R. M., Anderson, J. P., Wu, A. W., Mathews, C., Kozin, F., & Orenstein, D. (1989). The quality of well-being scale. Applications in AIDS, cystic fibrosis, and arthritis. Medical Care, 27, S27–S43.
Saigal, C. S., Cornbein, J., Nease, R., & Litwin, M. S. (2001). Predictors of utilities for health states in early stage prostate cancer. Journal of Urology, 166, 942–946.
Volk, R. J., Cantor, S. B., Cass, A. R., Spann, S. J., Weller, S. C., & Krahn, M. D. (2004). Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. Journal of General Internal Medicine, 19, 339–348.
Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences-lll: population and context effects. Journal of Clinical Epidemiology, 42, 585–592.
Gabriel, S. E., Kneeland, T. S., Melton 3rd. L. J., Moncur, M. M., Ettinger, B., & Tosteson, A. A. (1999). Health-related quality of life in economic evaluations for osteoporosis: Whose values should we use?. Medical Decision Making, 19, 141–148.
Sackett, D. L., & Torrance, G. W. (1978). The utility of different health states as perceived by the general public. Journal of Chronic Disease, 31, 697–704.
Polsky, D., Willke, R. J., Scott, K., Schulman, K. A., & Glick, H. A. (2001). A comparison of scoring weights for the EuroQol derived from patients and the general public. Health Economics, 10(1), 27–37.
Nease, R. F. J., Tsai, R., Hynes, L. M., & Littenberg, B. (1996). Automated utility assessment of global health. Quality of Life Research, 5, 175–182.
Chang, W. T., Collins, E. D., & Kerrigan, C. L. (2001). An Internet-based utility assessment of breast hypertrophy. Plastic & Reconstructive Surgery, 108, 370–377.
Lenert, L. A., Sturly, A., & Watson, M. E. (2002) iMPACT3: Internet-based development and administration of utility elicitation protocols. Medical Decision Making, 22, 464–474.
Bremner, K. E., Chong, C. A. K. Y., Tomlinson, G., Alibhai, S. M. H., & Krahn, M. D. (2007). A review and meta-analysis of prostate cancer utilities. Medical Decision Making, 27, 288–298.
Fryback, D. G., & Lawrence, W. F. Jr. (1997). Dollars may not buy as many QALYs as we think: A problem with defining quality-of-life adjustments. Medical Decision Making, 17, 276–284.
King, J. T., Styn, M. A., Tsevat, J., & Roberts, M. S. (2003). “Perfect Health” versus “Disease Free”: The impact of anchor point choice on the measurement of preferences and the calculation of disease-specific disutilities. Medical Decision Making, 23, 212–225.
Torrance, G. W. (1987). Utility approach to measuring health-related quality of life. Journal of Chronic Disease, 40, 593–600.
Furlong, W., Feeny, D., Torrance, G. W., Barr, R., & Horsman, J. (1990). Guide to design and development of health-state utility instrumentation. CHEPA Working Paper Series #90-9. Hamilton, Ontario, Canada: McMaster University.
Bennett, K. J., Torrance, G. W., Goldsmith, C. H., & Tugwell, P. (1991). Methodologic challenges in the development of utility measures of health related quality of life in rheumatoid arthritis. Controlled Clinical Trials, 12(suppl), 118–128.
Mohide, E. A., Torrance, G. W., Streiner, D. L., Pringle, D. M., & Gilbert, R. (1988). Measuring the well being of family caregivers using the time trade-off technique. Journal of Clinical Epidemiology, 41, 475–482.
Torrance, G., Keresteci, M. A., Casey, R. W., Rosner, A. J., Ryan, N., & Breton, M. C. (2004). Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function. Quality of Life Research, 13, 349–359.
Lenert, L., & Kaplan, R. M. (2000). Validity and interpretation of preference-based measures of health-related quality of life. Medical Care, 38(9, Suppl II), II-138–II-50.
Feeny, D., Blanchard, C. M., Mahon, J. L., Bourne, R., Rorabeck, C., Stitt, L., & Webster-Bogaert, S. (2004). The stability of utility scores: test–retest reliabilty and the interpretation of utility scores in elective total hip arthroplasty. Quality of Life Research, 13, 15–22.
Laupacis, A., Bourne, R., Rorabeck, C., Feeny, D., Wong, C., & Tugwell, P. (1993). Effect of elective total hip replacement upon health-related quality of life. Journal of Bone Joint Surgery, 75(11), 1619–1626.
Bennett, K. J., Torrance, G. W., Boyle, M. H., Guscott, R., & Moran, L. A. (2000). Development and testing of a utility measure for major, unipolar depression (McSad). Quality of Life Research, 9(1), 109–120.
Puhan, M. A., Guyatt, G. H., Montori, V. M., Bhandari, M., Devereaux, P. J., Griffith, L., Goldstein, R., & Schünemann, H. J. (2005). The standard gamble demonstrated lower reliability than the feeling thermometer. Journal of Clinical Epidemiology, 58, 458–465.
Schünemann, H. J., Griffith, L., Stubbing, D., Goldstein, R., & Guyatt, G. (2003). A clinical trial to evaluate the measurement properties of 2 direct preference instruments administered with and without marker states. Medical Decision Making, 23, 140–149.
Schünemann, H. J., Armstrong, D., Degl’innocenti, A., Wiklund, I., Fallone, C. A., Tanser, L., Van Zanten, S. V., Heels-Ansdell, D., El-Dika, S., Chiba, N., Barkun, A. N., Austin, P., & Guyatt, G. (2004). A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease. Medical Care, 42, 1132–1142.
Schünemann, H. J., Goldstein, R., Mador, M.J., McKim, D., Stahl, E., Griffith, L. E., Bayoumi, A. M., Austin, P., & Guyatt, G. (2006). Do clinical marker states improve the responsiveness and construct validity of the standard gamble and feeling thermometer: A randomized multi-center trial in patients with chronic respiratory disease. Quality of Life Research, 15, 1–14.
Bennett, K. J., Torrance, G. W., Moran, L. A., Smith, F., & Goldsmith, C. H. (1997). Health state utilities in knee replacement surgery: the development and evaluation of McKnee. Journal of Rheumatology, 24(9), 1796–1805.
Drummond, M. F., O’Brien, B., Stoddart, G. L., & Torrance, G. W. (1997). Chapter 6: Cost-utility analysis. Methods for the economic evaluation of health care programmes (pp. 139–204). New York: Oxford University Press.
Krahn, M. D., Mahoney, J. E., Eckman, M. H., Trachtenberg, J., Pauker, S. G., & Detsky, A. S. (1994). Screening for prostate cancer: a decision analytic view. JAMA, 272, 773–780.
Alibhai, S. M., Naglie, G., Nam, R., Trachtenberg, J., & Krahn, M. D. (2003). Do older men benefit from curative therapy of localized prostate cancer?. Journal of Clinical Oncology, 21(17), 3318–3327.
Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bezjak, A., Trachtenberg, J., et al. (2000). Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer. Journal of Clinical Epidemiology, 53, 920–930.
Krahn, M. D., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G. (2003). Patient and community preferences for outcomes in prostate cancer: Implications for clinical policy. Medical Care, 41, 153–164.
Ritvo, P., Irvine, J., Naglie, G., Tomlinson, G., Bezjak, A., Matthew, A., Trachtenberg, J., & Krahn, M. (2005). Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer. Journal of Clinical Epidemiology, 58, 466–474.
Feeny, D., Furlong, W., Boyle, M., & Torrance, G. W. (1995). Multi-attribute health status classification systems: Health Utilities Index. PharmacoEconomics, 7, 490–502.
Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., DePauw, S., Denton, M., & Boyle, M. (2002). Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 System. Medical Care, 40(2), 113–128.
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570–579.
Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., Pienta, K. J. (1997). Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology, 50(6), 920–928.
Shavelson, R. I., & Web, N. M. (1991). Generalizability theory: A primer. Newbury Park: Sage Publications Inc.
Spiegelhalter, D. J., Thomas, A., Best, N. G., & Lunn, D. (2004). WinBUGS User Manual. Version 1.4.1.
Brooks, S. P., & Gelman, A. (1998). Alternative methods for monitoring convergence of iterative simulations. Journal of Computational and Graphical Statistics, 7, 434–455.
R Development Core Team (2006). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
SPSS for Windows (2002) Release 11.5.0 ed. Chicago, Illinois: SPSS Inc.
Krahn, M., Bremner, K. E., Tomlinson, G., Ritvo, P., Irvine, J., & Naglie, G. (2007). Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Quality of Life Research, 16, 509–522.
Schünnemann, H. J., Stahl, E., Austin, P., Akl, E., Armstrong, D., & Guyatt, G. H. (2004). A comparison of narrative and table formats for presenting hypothetical health states to patients with gastrointestinal or pulmonary disease. Medical Decision Making, 24, 53–60.
Hays, R. D., Anderson, R., & Revicki, D. (1993). Psychometric considerations in evaluating health-related quality of life measures. Journal of Clinical Epidemiology, 2, 441–449.
Beaton, D. E., Bombardier, C., Katz, J. N., Wright, J. G. (2001). A taxonomy for responsiveness. Journal of Clinical Epidemiology, 54, 1204–1217.
Acknowledgements
The authors wish to acknowledge Dr. Gary Naglie, Dr. Jane Irvine and Dr. Paul Ritvo for their contributions to the development of the PORPUS-P and PORPUS-U. Financial support: This work was supported by grants from the National Cancer Institute of Canada, and the Canadian Institutes for Health Research. Dr. Krahn is supported by an Investigator Award from the Canadian Institutes for Health Research, and the F. Norman Hughes Chair in Pharmacoeconomics, Faculty of Pharmacy, University of Toronto.
Author information
Authors and Affiliations
Corresponding author
Additional information
Preliminary results of this study were presented at the 25th Annual Meeting of the Society for Medical Decision Making, Chicago, Illinois, October 18–22, 2003.
Rights and permissions
About this article
Cite this article
Bremner, K.E., Tomlinson, G. & Krahn, M.D. Marker states and a health state prompt provide modest improvements in the reliability and validity of the standard gamble and rating scale in prostate cancer patients. Qual Life Res 16, 1665–1675 (2007). https://doi.org/10.1007/s11136-007-9264-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-007-9264-7